Prilenia

Prilenia Therapeutics is a biopharmaceutical company focused on neurodegenerative diseases, developing pridopidine for Huntington’s disease and ALS

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

Prilenia Therapeutics is a biopharmaceutical company focused on neurodegenerative diseases, developing pridopidine for Huntington’s disease and ALS.

02Backed By1 investor

03Similar Companies

ST

Sage Therapeutics

Biotech & Life Sciences

→

NT

LT

T

AT

04Startup DNA

8

signals

Sectors
Business Model
Technology